Correlation Between Franklin Biotechnology and Franklin Moderate

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Franklin Biotechnology and Franklin Moderate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Biotechnology and Franklin Moderate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Franklin Biotechnology Discovery and Franklin Moderate Allocation, you can compare the effects of market volatilities on Franklin Biotechnology and Franklin Moderate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Biotechnology with a short position of Franklin Moderate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Biotechnology and Franklin Moderate.

Diversification Opportunities for Franklin Biotechnology and Franklin Moderate

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Franklin and Franklin is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Biotechnology Discove and Franklin Moderate Allocation in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Moderate and Franklin Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Biotechnology Discovery are associated (or correlated) with Franklin Moderate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Moderate has no effect on the direction of Franklin Biotechnology i.e., Franklin Biotechnology and Franklin Moderate go up and down completely randomly.

Pair Corralation between Franklin Biotechnology and Franklin Moderate

Assuming the 90 days horizon Franklin Biotechnology Discovery is expected to under-perform the Franklin Moderate. In addition to that, Franklin Biotechnology is 3.47 times more volatile than Franklin Moderate Allocation. It trades about -0.14 of its total potential returns per unit of risk. Franklin Moderate Allocation is currently generating about 0.06 per unit of volatility. If you would invest  1,606  in Franklin Moderate Allocation on September 19, 2024 and sell it today you would earn a total of  15.00  from holding Franklin Moderate Allocation or generate 0.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy97.62%
ValuesDaily Returns

Franklin Biotechnology Discove  vs.  Franklin Moderate Allocation

 Performance 
       Timeline  
Franklin Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Franklin Moderate 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Franklin Moderate Allocation are ranked lower than 3 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Franklin Moderate is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Franklin Biotechnology and Franklin Moderate Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Franklin Biotechnology and Franklin Moderate

The main advantage of trading using opposite Franklin Biotechnology and Franklin Moderate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Biotechnology position performs unexpectedly, Franklin Moderate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Moderate will offset losses from the drop in Franklin Moderate's long position.
The idea behind Franklin Biotechnology Discovery and Franklin Moderate Allocation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance